Nike Analysts Remain Bearish Despite 'Full Stride Ahead' Plan, Cite Sales Decline In FY28

Shares of Nike Inc (NYSE:NKE) came under pressure in early trading on Wednesday, after the company’s Investor Day when it announced its outlook.

Here are some key analyst takeaways:

Check out other analyst stock ratings.

JPMorgan: Under Nike’s "Full Stride Ahead" strategy, CEO Elliott Hill said the company leads a $330 billion athletic apparel and footwear market projected to grow 3%-4% annually, noting the sport category’s opportunity "has never been greater," Boss said in a note.

CFO Dave Denton outlined the fiscal 2031 plan that includes around $5 billion of incremental revenue growth off the fiscal 2027 base, the analyst noted. This translates to revenues of about $47.8 billion by fiscal 2031, he added.

Denton also set a target of 12%-14% EBIT margins by that year, which translates to adjusted earnings of $3.00 to $3.50 per share, Boss stated.

BofA Securities: Nike outlined another year of declines in both sales and earnings in fiscal 2028, with an inflection in fiscal 2029, Hutchinson stated.

The company’s fiscal 2031 targets, including operating margin of 12%-14% and earnings of $3.00-$3.50 per share, "appear optimistic and require improved product newness and marketplace while delivering substantial cost savings," she added.

The analyst expressed concern about uncertainty around Nike’s recovery through "another 18 months of deteriorating fundamentals."

Management expects Greater China revenue to remain flat in fiscal 2031 versus fiscal 2027, despite around 5% annual market growth, she noted.

While Nike is making efforts that "should improve local relevance," the market remains "extremely competitive" and the company would need to continue investing to maintain sales at current levels, Hutchinson further said.

NKE Price Action: Shares of Nike had risen by 2.04% to $36.58 at the time of publication on Wednesday.

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs
Share this article